ENIGMA THERAPEUTICS Trademark

Trademark Overview

On Friday, May 17, 2024, a trademark application was filed for ENIGMA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ENIGMA THERAPEUTICS trademark a serial number of 98556226. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, December 16, 2024. This trademark is owned by Enigma Therapeutics Ltd.. The ENIGMA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders; pharmaceutical compositions for the treatment of autoimmune diseases and disorders; biotechnological preparations for medical use; biotechnological preparations for the treatment of oncological diseases and disorders; biotechnological preparations for the treatment of autoimmune diseases and disorders; antibodies; antibodies for medical use; antigens; antigens for medical use; none of the aforementioned goods for dental purposes

Pharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development services; pharmaceutical research; biochemical research and analysis; clinical trials; genome organization and functional analysis; genetic testing for scientific research; research and development services in the field of immunology, biotechnology, oncology, medicine, gene therapy, immunotherapy and therapeutics; research and development services in the field of antibodies and antigens; technological services related to manufacture of pharmaceuticals; laboratory services relating to the production of monoclonal antibodies; design of manufacturing methods for pharmaceuticals; advisory, information and consultancy services relating to the aforementioned services; none of the aforementioned services in relation to dentistry
enigma therapeutics

General Information

Serial Number98556226
Word MarkENIGMA THERAPEUTICS
Filing DateFriday, May 17, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateMonday, December 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; pharmaceutical preparations and substances for the treatment of autoimmune diseases and disorders; pharmaceutical compositions for the treatment of autoimmune diseases and disorders; biotechnological preparations for medical use; biotechnological preparations for the treatment of oncological diseases and disorders; biotechnological preparations for the treatment of autoimmune diseases and disorders; antibodies; antibodies for medical use; antigens; antigens for medical use; none of the aforementioned goods for dental purposes
Goods and ServicesPharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development services; pharmaceutical research; biochemical research and analysis; clinical trials; genome organization and functional analysis; genetic testing for scientific research; research and development services in the field of immunology, biotechnology, oncology, medicine, gene therapy, immunotherapy and therapeutics; research and development services in the field of antibodies and antigens; technological services related to manufacture of pharmaceuticals; laboratory services relating to the production of monoclonal antibodies; design of manufacturing methods for pharmaceuticals; advisory, information and consultancy services relating to the aforementioned services; none of the aforementioned services in relation to dentistry

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 17, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 17, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEnigma Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressHertfordshire AL87EE
GB

Trademark Events

Event DateEvent Description
Friday, May 17, 2024NEW APPLICATION ENTERED
Wednesday, November 20, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 3, 2024ASSIGNED TO EXAMINER
Monday, December 16, 2024NON-FINAL ACTION E-MAILED
Monday, December 16, 2024NON-FINAL ACTION WRITTEN
Monday, December 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

therapeutics enigma services research pharmaceutical disorders diseases development treatment preparations antibodies antigens